Bosh sahifa500087 • BOM
add
Cipla Ltd
Yopilish kursi
1 554,40 ₹
Kunlik diapazon
1 531,00 ₹ - 1 557,70 ₹
Yillik diapazon
1 310,05 ₹ - 1 702,00 ₹
Bozor kapitalizatsiyasi
1,25 trln INR
Oʻrtacha hajm
35,58 ming
Narx/foyda
25,07
Dividend daromadliligi
0,84%
Asosiy maydon
NSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 69,62 mlrd | 7,01% |
Joriy xarajat | 29,88 mlrd | 7,81% |
Sof foyda | 15,71 mlrd | 48,74% |
Sof foyda marjasi | 22,56 | 39,00% |
Har bir ulushga tushum | 19,43 | 71,62% |
EBITDA | 19,19 mlrd | 10,19% |
Amaldagi soliq stavkasi | 17,43% | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 87,08 mlrd | 78,06% |
Jami aktivlari | — | — |
Jami passivlari | — | — |
Umumiy kapital | 284,56 mlrd | — |
Tarqatilgan aksiyalar | 807,46 mln | — |
Narxi/balansdagi bahosi | 4,43 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 14,78% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 15,71 mlrd | 48,74% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
CEO
Tashkil etilgan
1935
Bosh ofis
Sayt
Xodimlar soni
27 764
